Evaluation of the NCCN guidelines using the RIGHT Statement and AGREE-II instrument: a cross-sectional review
| Autor: | Craig Cooper, Matt Vassar, Cole Wayant, D'Arcy Turner |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Quality Assurance Health Care Statement (logic) media_common.quotation_subject 03 medical and health sciences 0302 clinical medicine Neoplasms Health care medicine Humans Agree ii Quality (business) 030212 general & internal medicine media_common Evidence-Based Medicine business.industry General Medicine Guideline Checklist Cross-Sectional Studies 030228 respiratory system Family medicine Practice Guidelines as Topic Guideline Adherence Psychology business Healthcare providers Strengths and weaknesses |
| Zdroj: | BMJ evidence-based medicine. 24(6) |
| ISSN: | 2515-4478 |
| Popis: | IntroductionRobust, clearly reported clinical practice guidelines (CPGs) are essential for evidence-based clinical practice. The Reporting Items for practice Guidelines in HealThcare (RIGHT) Statement and Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument were published to improve the methodological and reporting quality in healthcare CPGs.MethodsWe applied the RIGHT Statement checklist and AGREE-II instrument to 48 National Comprehensive Cancer Network (NCCN) guidelines. Our primary objective was to assess the adherence to RIGHT and AGREE-II items. Since neither RIGHT nor AGREE-II can judge the clinical usefulness of a guideline, our study is designed to only focus on the methodological and reporting quality of each guideline.ResultsThe NCCN guidelines demonstrated notable strengths and weaknesses. For example, RIGHT Statement items 19 (conflicts of interest), 7b (description of subgroups) and 13a (clear, precise recommendations) were fully reported in all guidelines. However, the guidelines inconsistently incorporated patient values and preferences and cost. Regarding the AGREE-II instrument, the NCCN guidelines scored highly on the domains 4 (clear, precise recommendations) and 6 (handling of conflicts of interest), but lowest on domain 2 (inclusion of all relevant stakeholders).ConclusionsIn this investigation, we found that NCCN CPGs demonstrate key strengths and weaknesses with respect to the reporting of key items essential to CPGs. We recommend the continued use of NCCN guidelines and improvements to weaknesses in reporting and methods. Doing so serves to improve the evidence delivered to healthcare providers, thus potentially improving patient care. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|